HDAC6 and triple-negative breast carcinoma: These experiments were carried out on an HCC38 triple-negative breast cancer cell line with stimulation over eighteen hours by erastin (ferroptosis inducer), tubacin (HDAC6 inhibitor) and combination of the two molecules (combo) (Figure 3D).